Helped along by sales gains for its Neutrogena and Aveeno skin care brands, Johnson & Johnson today said worldwide consumer product sales rose 1.7% to $14.7 billion in 2013. Also providing a lift were international sales of Listerine oral care products.
Overall, worldwide sales for the full-year 2013 rose 6.1% to $71.3 billion. Net income was $13.8 billion.
Neutrogena and Aveeno Lift J&J's 2013 Results
Published January 21, 2014
blog comments powered by Disqus